AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 268 filers reported holding AVANOS MED INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,403,000 | +22.4% | 161,291 | +26.6% | 0.00% | +50.0% |
| Q4 2021 | $4,416,000 | +30.1% | 127,366 | +17.0% | 0.00% | 0.0% |
| Q3 2021 | $3,395,000 | -7.5% | 108,828 | +7.8% | 0.00% | 0.0% |
| Q2 2021 | $3,670,000 | +10.5% | 100,908 | +32.9% | 0.00% | 0.0% |
| Q1 2021 | $3,321,000 | -1.2% | 75,924 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $3,360,000 | +32.8% | 73,233 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $2,530,000 | +16.1% | 76,151 | +2.7% | 0.00% | 0.0% |
| Q2 2020 | $2,180,000 | -13.9% | 74,175 | -21.1% | 0.00% | 0.0% |
| Q1 2020 | $2,532,000 | +6.6% | 94,024 | +33.4% | 0.00% | 0.0% |
| Q4 2019 | $2,375,000 | -24.4% | 70,482 | -16.0% | 0.00% | -33.3% |
| Q3 2019 | $3,143,000 | -24.5% | 83,907 | -12.1% | 0.00% | 0.0% |
| Q2 2019 | $4,162,000 | -13.3% | 95,442 | -15.1% | 0.00% | -25.0% |
| Q1 2019 | $4,798,000 | -8.3% | 112,422 | -3.7% | 0.00% | -20.0% |
| Q4 2018 | $5,231,000 | -60.9% | 116,779 | -40.2% | 0.01% | -58.3% |
| Q3 2018 | $13,366,000 | – | 195,124 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |